So far, Pathways has cost state and federal taxpayers nearly $9,000 per enrollee, largely back-end costs to run the program.

Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...

Deep funding cuts and staff layoffs threaten current and future research on cancer, liver disease, HIV, COVID and other ...

Prostate cancer blogger Dan Zeller shares an item that had him LOLing. Okay. Now I’ve seen everything. This ad for prostate ...

The scientist studies data on gender identity and sexual orientation. Here’s why that’s vital for cancer research and health ...

Those who were treated with celecoxib, a non-steroidal anti-inflammatory drug, experienced significantly improved ...

Preventing the cell’s protein factories from making the cancer-causing protein MYC could stop out-of-control tumors.

Spend billions of dollars to cover anti-obesity drugs under Medicare and Medicaid, or deny more than 7 million people access ...

“Any cuts to Medicaid would significantly jeopardize critical health care access for millions of people in America. Research ...

Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for ...

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...

There’s a lack of research on whether cat biology makes them more susceptible to H5N1 than other mammals, including humans, ...